Barclays PLC Makes New $35.08 Million Investment in Healthpeak Properties, Inc. (NYSE:DOC)

Barclays PLC bought a new stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 1,533,765 shares of the real estate investment trust’s stock, valued at approximately $35,078,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. HM Payson & Co. purchased a new position in Healthpeak Properties in the third quarter valued at about $25,000. S.A. Mason LLC acquired a new position in shares of Healthpeak Properties in the 3rd quarter valued at approximately $26,000. Rise Advisors LLC purchased a new position in shares of Healthpeak Properties during the 3rd quarter valued at approximately $29,000. Fortitude Family Office LLC acquired a new stake in shares of Healthpeak Properties during the third quarter worth approximately $32,000. Finally, Barrett & Company Inc. bought a new stake in shares of Healthpeak Properties in the third quarter worth $33,000. 93.57% of the stock is owned by hedge funds and other institutional investors.

Healthpeak Properties Stock Down 0.8 %

DOC stock opened at $20.76 on Friday. The stock has a market cap of $14.52 billion, a PE ratio of 44.17, a price-to-earnings-growth ratio of 2.37 and a beta of 1.13. The firm’s 50-day simple moving average is $21.94 and its 200 day simple moving average is $21.35. Healthpeak Properties, Inc. has a fifty-two week low of $16.01 and a fifty-two week high of $23.26. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 0.93.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 EPS for the quarter, missing the consensus estimate of $0.44 by ($0.32). The firm had revenue of $700.40 million during the quarter, compared to the consensus estimate of $682.51 million. Healthpeak Properties had a return on equity of 3.53% and a net margin of 12.10%. Healthpeak Properties’s revenue for the quarter was up 25.9% on a year-over-year basis. During the same quarter last year, the company posted $0.45 EPS. As a group, sell-side analysts predict that Healthpeak Properties, Inc. will post 1.8 EPS for the current year.

Healthpeak Properties Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 5.78%. The ex-dividend date of this dividend was Monday, November 4th. Healthpeak Properties’s payout ratio is currently 255.32%.

Analysts Set New Price Targets

DOC has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft raised shares of Healthpeak Properties from a “hold” rating to a “buy” rating and raised their price objective for the stock from $20.00 to $28.00 in a report on Monday, October 21st. Wells Fargo & Company decreased their price target on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research note on Tuesday. Mizuho cut their price objective on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research note on Thursday, December 5th. Royal Bank of Canada lifted their target price on Healthpeak Properties from $25.00 to $26.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Finally, Evercore ISI upped their price target on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research report on Monday, September 16th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $22.93.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.